Lingzhuo Kong

Lingzhuo Kong

Auto-generated profile, based on publicly available information

Lingzhuo Kong

Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2025 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SSSaboor Saeed
Saboor Saeed
HWHuaizhi Wang
Huaizhi Wang
LKLingzhuo Kong
Lingzhuo Kong
YGYimeng Geng
Yimeng Geng
JZJinyu Zhang
Jinyu Zhang
SHShaohua Hu
Shaohua Hu

16 December 2025 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
PDF file
CXChenyue Xu
Chenyue Xu
LKLingzhuo Kong
Lingzhuo Kong
TMTingting Mou
Tingting Mou
ATAnying Tang
Anying Tang
SHShaohua Hu
Shaohua Hu
JLJianbo Lai
Jianbo Lai
Accumulating evidence highlights the role of Vitamin B12 (VitB12) in the pathophysiology of affective disorders. However, its influence on brain function and the underlying mechanisms remain incompletely understood. In humans, VitB12 is obtained solely from dietary sources, primarily animal-based foods. VitB12 deficiency leads to the accumulation of homocysteine, a known contributor to emotional and behavioral dysregulation. VitB12 plays a critical role in maintaining neuron stability, synapsis plasticity, and regulating neuroinflammation by modulating key bioactive factors. These processes help to alleviate hippocampal damage, mitigate blood-brain barrier disruption, reduce oxidative stress, and enhance both structural and functional connectivity—collectively contributing to resilience against affective disorders. VitB12 from both diet and microbial sources is essential to gut homeostasis. Within the gut lumen, it stabilizes gut microbial communities, promotes short-chain fatty acid (SCFA) production, and supports neurotransmitter metabolism (e.g., serotonin and dopamine) via its role in S-adenosyl-l-methionine biosynthesis. Crucially, VitB12, gut microbiota, SCFAs, intestinal mucosa, and vagal nerve signaling interact synergistically within the gut-brain axis (GBA) to maintain gut microenvironment stability, protect the gut-blood barrier, and suppress neuroinflammatory cascades, eventually reducing the susceptibility to affective disorders. This review synthesizes current evidence on the involvement of VitB12 in the GBA, its association with mood regulation, and its potential as a nutritional adjunct in managing affective disorders. By elucidating this integrative mechanism, we provide new insights into targeting the GBA to improve clinical outcomes in affective disorders.

5 October 2025 in Actas Españolas de Psiquiatría
Verified
Journal Article
Open access
PDF file
TMTingting Mou
Tingting Mou
JLJianbo Lai
Jianbo Lai
LKLingzhuo Kong
Lingzhuo Kong
Background: Dysregulation of coagulation function associated with antipsychotic treatment remains poorly understood. This study investigates the potential impact of paliperidone on serum D-dimer levels during the early stages of treatment. Methods: Nine patients diagnosed with first-episode schizophrenic spectrum disorder were assessed for serum D-dimer levels before and after a 2-week paliperidone regimen. Additionally, eight adult C57 mice in the experimental group (EG) received 3 mg/kg of paliperidone daily for 10 consecutive days, while eight mice in the control group (CG) were untreated. Venous blood was collected and analyzed for D-dimer at baseline, and on the 5th and 10th days in the EG, as well as on the 10th day for the CG. Results: No significant differences were observed in serum D-dimer levels before and after paliperidone treatment in the patient cohort. In animal experiments, compared to the CG on the 10th day, serum D-dimer levels in the EG on the 10th day showed no significant difference (p > 0.05), while the level in the EG on the 5th day was significantly lower (p < 0.05). Compared to its baseline, serum D-dimer levels within the EG on the 5th day was significantly decreased (p < 0.05). Conclusion: Short-term paliperidone treatment had minimal effects on serum D-dimer levels in both human participants and mice, though transient changes were noted early in treatment. Nonetheless, the potential for drug-induced coagulation disruption should be considered in clinical practice.

15 April 2026 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
LKLingzhuo Kong
Lingzhuo Kong
YYYan Yang
Yan Yang
WZWeihua Zhou
Weihua Zhou
SHShaohua Hu
Shaohua Hu
Alzheimer's disease (AD) is among the main causes of cognitive impairment, memory loss, and dementia, particularly in old adults. It has been listed as one of the most expensive, lethal, and burdening diseases of the 21st century and develops with the process of aging worldwide (Scheltens et al., 2021). Currently, it is widely acknowledged that the typical pathogenesis of AD involves the deposition of amyloid-β (Aβ) and Tau proteins in the cerebral parenchyma and vasculature, intraneuronal neurofibrillary tangles, and the gradual degeneration of synapses (Scheltens et al., 2016; Rostagno, 2022). According to several hypotheses, abnormalities and dysfunctions in vascular structure, mitochondrial metabolism, oxidative stress, glucose utilization, and neuroinflammation are considered fundamental for AD pathology (Scheltens et al., 2016).

24 July 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
XGXiaonan Guo
Xiaonan Guo
YFYu Feng
Yu Feng
PHPeng Huang
Peng Huang
NJNingning Jia
Ningning Jia
ZQZeyu Qin
Zeyu Qin
SHShaohua Hu
Shaohua Hu
Obesity and psychiatric disorders frequently co-occur, yet the heterogeneous genetic mechanisms underlying this comorbidity remain elusive. Here, we stratify the polygenic architecture of body mass index (BMI) into five biologically distinct clusters based on metabolic signatures and construct partitioned polygenic scores (pPGSs) for each. Using individual-level data from the UK Biobank (N = 310,708), we identify cluster-specific psychiatric risk profiles, with amino acid-related clusters showing the strongest associations. These effects are markedly modulated by sex and BMI: underweight individuals and females show amplified psychiatric vulnerability, while obesity attenuates certain associations. Integration of proteomic and metabolomic data reveals key molecular mediators, including TNN, LEP, and ANGPT2, that influence psychiatric outcomes in a BMI- and sex-dependent manner. Mediation analyses demonstrate that pPGSs primarily exert indirect effects on psychiatric disorders through immune and metabolic molecular networks. These findings highlight the functional heterogeneity of BMI genetics, providing a framework for precision psychiatry.

16 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LKLingzhuo Kong
Lingzhuo Kong
JDJia-Hao Ding
Jia-Hao Ding
TXTingting Xie
Tingting Xie
JWJian Wang
Jian Wang
ZGZhen Gao
Zhen Gao
YWYumei Wang
Yumei Wang
Background: Diet, sleep, depressive symptoms and cardiometabolic disorders cluster across populations, but integrated evidence linking nutrient composition to mood-sleep and metabolic burden remains limited. Methods: We analyzed data of adults in the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018 using survey-weighted models of energy-adjusted nutrients, Patient Health Questionnaire-9 (PHQ-9) scores, sleep phenotypes, cardiometabolic outcomes and linked mortality. Frozen equations were developed and temporally validated, and a primary translational tool MeaLink was created based on the equations. Results: Among 34,522 eligible adults individuals, nutrient signals were consistent across mood, sleep and cardiometabolic outcomes. Per 1-standard derivation (SD) higher total sugar energy share, PHQ-9 score was 0.27 points higher and odds of probable depression were 18% higher (odd ratio (OR) = 1.18); per 1-SD higher selenium density, PHQ-9 score was 0.25 points lower and odds of probable depression were 19% lower (OR = 0.81). Compared with the lowest quartile, the highest fiber quartile was associated with lower PHQ-9 score (beta = -0.56), 19% lower odds of short sleep (OR = 0.81) and 23% lower odds of metabolic syndrome (OR = 0.77). Per 1-SD higher magnesium density, odds of metabolic syndrome were 15% lower (OR = 0.85), fasting insulin was 8.8% lower and HOMA-IR was 9.3% lower. Equations for depression, metabolic syndrome and high cardiometabolic burden showed optimism-corrected C-statistics of 0.799, 0.870 and 0.847, with temporal-validation values of 0.805, 0.878 and 0.836. Calibration was close to ideal except for modest high-burden over-prediction, decision curves were favorable across prespecified thresholds, and external proxy datasets supported 12 of 13 displayed validation targets. Conclusion: These findings provide actionable dietary targets for the clinical management of depression-insomnia comorbidity, and highlight a population-health opportunity to integrate nutrition, sleep and mental-health assessment into cardio-metabolic prevention for a wide range of population.